文献速递肿瘤 PET/CT骨显像与常规 SPECT核素与放射性配体治疗

一例由枕骨大孔间叶肿瘤所致肿瘤性骨软化症的罕见病例:术前经68Ga-DOTATATE PET/CT诊断

A Rare Case of Tumor-Induced Osteomalacia Due to Mesenchymal Tumor at Foramen Magnum Diagnosed Preoperatively on 68 Ga DOTATATE PET/CT.
PubMed 文献 · Clin Nucl Med · 2024-10-21

一名42岁男性FGF23依赖性低磷血症患者行68Ga-DOTATATE PET/CT,显示枕骨大孔左弓处生长抑素受体表达病灶,MRI对应为2.2×1.3 cm软组织病灶;切除后病理证实为磷酸盐尿性间叶肿瘤,术后临床改善且低磷血症完全恢复。

要点

  • 肿瘤性骨软化症患者68Ga-DOTATATE PET/CT出现局灶性摄取时需广泛排查非常规部位间叶肿瘤。
  • 本例病灶位于枕骨大孔左弓,MRI对应为2.2×1.3 cm软组织病灶。
  • 病灶切除后病理证实为磷酸盐尿性间叶肿瘤,患者术后低磷血症完全恢复。

核心结论

  • 肿瘤性骨软化症患者68Ga-DOTATATE PET/CT出现局灶性摄取时需广泛排查并保持高度怀疑,以排除位于非常规部位的间叶肿瘤,如本例枕骨大孔病灶。

研究设计与样本

  • 个案报道:一名42岁男性FGF23依赖性低磷血症患者,行68Ga-DOTATATE PET/CT及MRI,病灶切除后行组织病理学检查。

主要发现

  • 68Ga-DOTATATE PET/CT显示枕骨大孔左弓处生长抑素受体表达病灶,MRI对应为2.2×1.3 cm软组织病灶。
  • 病灶切除后组织病理学证实为磷酸盐尿性间叶肿瘤。
  • 术后患者临床改善,低磷血症完全恢复。

临床怎么用

  • 原文结论指出肿瘤性骨软化症患者68Ga-DOTATATE PET/CT出现局灶性摄取时需广泛排查并保持高度怀疑,以排除非常规部位间叶肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 42-year-old man, a known case of FGF23-dependent hypophosphatemia, underwent 68 Ga- DOTATATE PET-CT, which showed a somatostatin receptor-expressing lesion in the left arch of foramen magnum that was correlated on MRI as a soft tissue lesion measuring 2.2 × 1.3 cm. It was excised and histopathologically confirmed as phosphaturic mesenchymal tumor. Postoperatively, patient improved clinically and recovered from hypophosphatemia completely. A distinct focal uptake in a 68 Ga- DOTATATE PET-CT in a patient with tumor-induced osteomalacia needs extensive workup and high degree of suspicion to rule out mesenchymal tumor at nonconventional location as seen in the present case.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mouli C, Lila A, Gondhane A, et al. A Rare Case of Tumor-Induced Osteomalacia Due to Mesenchymal Tumor at Foramen Magnum Diagnosed Preoperatively on 68 Ga DOTATATE PET/CT. Clin Nucl Med. 2024. PMID: 39479992. doi:10.1097/RLU.0000000000005549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。